Moderna's Flu Vaccine Now Available, Promising Greater Effectiveness
· Telemundo McAllen (KTLM)
Moderna's mFlusiva, the first mRNA flu vaccine in the U.S., is now available but is limited to individuals aged 50 and older. This innovative vaccine is designed to be more effective and quicker to produce compared to traditional flu vaccines. In clinical trials, mFlusiva showed about 27% greater efficacy than standard flu shots. The FDA approved it in August, but confusion remains about eligibility and availability. While the vaccine is not intended for those under 50, traditional flu vaccines are still an option. Pricing for mFlusiva is around $171 per dose without insurance, with some pharmacies offering lower prices.
AI summary · Source: Telemundo McAllen (KTLM) →
